Jiří Pavlů

Assessment of <i>BCR-ABL1</i> Transcript Levels at 3 Months Is the Only Requirement for Predicting Outcome for Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors

David Marín, Amr R. Ibrahim, Claire Lucas et al. · Journal of Clinical Oncology · 2011 · 474 citations · Full text

European LeukemiaNet criteria for failure or suboptimal response reliably identify patients with CML in early chronic phase treated with imatinib whose eventual outcome is poor

David Marín, Dragana Milojković, Eduardo Olavarría et al. · Blood · 2008 · 328 citations · Full text

Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemia

Kate Stringaris, Takuya Sekine, A. Khoder et al. · Haematologica · 2014 · 231 citations · Full text

Mixed-phenotype Acute Leukemia, Innate Immune System, Immunology +20

Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation

Aristeidis Chaidos, Scott D. Patterson, Richard Szydlo et al. · Blood · 2012 · 161 citations · Full text

Augmented Reduced-Intensity Regimen Does Not Improve Postallogeneic Transplant Outcomes in Acute Myeloid Leukemia

Charles Craddock, Aimee Jackson, Justin Loke et al. · Journal of Clinical Oncology · 2020 · 158 citations · Full text